Article Text

Download PDFPDF
EP054 A subpectineal obturator nerve block reduces opioid consumption by 40% after hip arthroscopy: a triple-blind, randomized, placebo-controlled trial
  1. Christian Jessen1,2,
  2. Ulrick Skipper Espelund1,2,
  3. Lone Dragnes Brix1,
  4. Thomas Dahl Nielsen3,
  5. Bent Lund2,4 and
  6. Thomas Fichtner Bendtsen2,3
  1. 1Department of Anesthesiology and Intensive Care, Horsens Regional Hospital, Horsens, Denmark, Horsens, Denmark
  2. 2Department of Clinical Medicine, Faculty of Health, Aarhus University, Aarhus, Denmark, Aarhus, Denmark
  3. 3Department of Anesthesiology, Aarhus University Hospital, Aarhus, Denmark, Aarhus, Denmark
  4. 4Department of Orthopedic Surgery, Horsens Regional Hospital, Horsens, Denmark, Horsens, Denmark

Abstract

Please confirm that an ethics committee approval has been applied for or granted: Yes: I’m uploading the Ethics Committee Approval as a PDF file with this abstract submission

Background and Aims Hip arthroscopy causes severe pain the first hours postoperative, probably due to the stretching of the hip joint capsule during surgery. Postoperative pain control is often achieved by high doses of opioids. This may cause opioid related adverse events and prolong recovery. The nociceptors in the hip joint capsule are mainly located anteriorly where the obturator nerve innervates the anteromedial part. We hypothesized that a subpectineal obturator nerve block would reduce the postoperative opioid consumption.

Methods Forty ambulatory hip arthroscopy patients were enrolled in this randomized, triple-blind controlled trial approved by the Danish National Center for Ethics. All patients were allocated to a preoperative active or placebo subpectineal obturator nerve block. The primary outcome was opioid consumption the first three hours. Secondary outcomes were pain, nausea, and adductor strength.

Results Thirty-four patients were analyzed. The mean intravenous morphine equivalent consumption was reduced by 40% in the subpectineal obturator nerve block group versus the placebo group, 11.9 mg versus 19.7 mg respectively (p<0.001). See figure 1. The hip adductor strength was significantly reduced in the active group versus the placebo group, with a relative pre-/postoperative adductor strength reduction, 80% versus 38% respectively (p<0.001). No other intergroup differences were observed regarding the secondary outcomes.

Abstract EP054 Figure 1

Scatter plot of the difference between an active and placebo subpectineal obturator nerve block on consumption of intravenous morphine equivalents during the first three postoperative hours. SOB, Subpectineal Obturator Nerve Block; IV, Intravenous; mg, milligram; Gray/Black diamond, mean opioid consumption

Conclusions A subpectineal obturator nerve block significantly reduced the postoperative opioid consumption by 40% after hip arthroscopy in this randomized, triple-blind trial.

  • Obturator Nerve Block
  • Opioid Reduction
  • UGRA
  • Hip arthroscopy
  • Pain
  • RCT.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.